We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 616

Grassley pressures CMS and DOJ to increase scrutiny of Medicare Advantage plans
  • Sidley Austin LLP
  • USA
  • May 21 2015

On May 19, Senator Charles Grassley sent letters to Attorney General Loretta Lynch (here) and to the Acting Administrator of CMS (here) demanding


California Supreme Court accepts for review important California meal period waiver case
  • Sidley Austin LLP
  • USA
  • May 20 2015

We previously reported on Gerard v. Orange Coast Memorial Medical Center, which was a decision by a California Court of Appeal to invalidate a


China lifts drug price controls but heightens drug price monitoring and enforcement
  • Sidley Austin LLP
  • China
  • May 14 2015

On May 4, 2015, seven Chinese government agencies jointly announced that they will lift price controls for most drug products, and establish a


FDA withdraws 2004 disease awareness guidance
  • Sidley Austin LLP
  • USA
  • May 7 2015

On May 6, the Food and Drug Administration (FDA) announced it was withdrawing the 2004 draft guidance on "help-seeking" and other disease awareness


New EU Guideline facilitates global development of biosimilars
  • Sidley Austin LLP
  • European Union
  • May 4 2015

On April 30, 2015, a new EU Guideline on biosimilar medicines took effect. The new Guideline defines a number of concepts applied by the EMA in its


OIG warns that laboratory fee waiver arrangement could violate AKS and “substantially in excess” provision
  • Sidley Austin LLP
  • USA
  • April 28 2015

Clinical laboratories should take heed of recently released Advisory Opinion 15-04 (March 25, 2015, see the


ONC and OCR release updated Guide to privacy and security of electronic health information
  • Sidley Austin LLP
  • USA
  • April 27 2015

Recently, the Office of the National Coordinator for Health Information Technology (ONC) and the Office for Civil Rights (OCR) published new guidance


CFDA reveals initiatives of regulatory reform
  • Sidley Austin LLP
  • China
  • April 17 2015

The China Food and Drug Administration (CFDA) recently revealed its 2015 key regulatory reform initiatives in the area of drug review and approval


Eastern District of Louisiana holds Government to same discovery standards as mere mortals
  • Sidley Austin LLP
  • USA
  • April 17 2015

In a recent, sharply worded order, E.D. La. Magistrate Judge Joseph Wilkinson recently rejected the U.S. Justice Department's objections of undue


EEOC issues highly-anticipated proposed rule on wellness programs and the ADA
  • Sidley Austin LLP
  • USA
  • April 16 2015

How far is too far in managing workplace wellness? We asked the same question last fall after the U.S. Equal Employment Opportunity Commission